TESTOSTERONE REDUCES NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) OF HYPOGONADISM

被引：0
|
作者：
Nikolaenko, L. [1 ]
Diaz-Arjonilla, M. [1 ]
Laurel, S. [1 ]
Wang, C. [1 ]
Lue, Y. [1 ]
French, S.
Swerdloff, R. [1 ]
机构：
[1] Harbor UCLA Med Ctr, LA Biomed Res Inst, Torrance, CA 90509 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2010年 / 58卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
64
引用
收藏
页码：120 / 120
页数：1
相关论文
共 50 条
  • [31] Leptin as a marker of liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Petrovic, LM
    Alba, LM
    Lindor, KD
    Talwakar, JA
    Angulo, P
    LABORATORY INVESTIGATION, 2003, 83 (01) : 283A - 283A
  • [32] Leptin as a marker of liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Petrovic, LM
    Alba, LM
    Lindor, KD
    Talwakar, JA
    Angulo, P
    MODERN PATHOLOGY, 2003, 16 (01) : 283A - 283A
  • [33] Liver Biopsy and Non-alcoholic Fatty Liver Disease (NAFLD) in Bariatric Patients
    Kanakala, V.
    Chattopadhyay, D.
    Sarkar, R.
    Balupuri, S.
    Small, P. K.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 285 - 285
  • [34] Non-alcoholic Fatty Liver Disease (NAFLD) and non-alcoholic Steatohepatitis (NASH): Pathophysiology and Nutritional Aspects
    Schattenberg, Joern M.
    ERNAHRUNGS UMSCHAU, 2015, 62 (02): : M92 - M100
  • [35] Non-alcoholic fatty liver disease (NAFLD) models in drug discovery
    Cole, Banumathi K.
    Feaver, Ryan E.
    Wamhoff, Brian R.
    Dash, Ajit
    EXPERT OPINION ON DRUG DISCOVERY, 2018, 13 (02) : 193 - 205
  • [36] In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
    Kanuri, Giridhar
    Bergheim, Ina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (06): : 11963 - 11980
  • [37] Non-alcoholic fatty liver disease (NAFLD) among underweight adults
    Fahim, Shah Mohammad
    Chowdhury, Muhammad Abdul Baker
    Alam, Shahinul
    CLINICAL NUTRITION ESPEN, 2020, 38 : 80 - 85
  • [38] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course
    Cortez-Pinto, H
    Camilo, ME
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1089 - 1104
  • [39] Linagliptin is an Effective Therapeutic for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH)
    Klein, Thomas
    Mark, Michael
    DIABETES, 2012, 61 : A265 - A266
  • [40] Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Miele, Luca
    Forgione, Alessandra
    Gasbarrini, Giovanni
    Grieco, Antonio
    TRANSLATIONAL RESEARCH, 2007, 149 (03) : 114 - 125
12345